Sanghi Medical Centre, a renowned NABL accredited Pathlab starts Antibody Testing for Covid-19

New Delhi | 22nd July 2020: Sanghi Medical Centre, a reputed, world-class, multi-specialty NABL-accredited pathlabhas joined the league of private labs in Delhi offering antibody testing for Covid-19 (IgG). The simple blood test is used to assess if a person has been exposed to the novel coronavirus infection or not, using highly sofiscicated immune assay analyzer. The brand has over 10 labs across India and has been delivering top notch healthcare services since over 35 years.

Sanghi Medical Centre

With Sanghi Medical Centre, a person can be assured of highly accurate and fast results. The labworks with trained personnel, offering optimum safety for all those who get the test done. It has an extensive array of offerings, alongside an unwavering adherence to the stringent global standards. The lab has to its credit the prestigious National Accreditation Board for Testing and Calibration of Laboratories (NABL) accreditation for its Pathology Laboratory, the top accreditation for any laboratory in India.

Speaking about this, Dr Vikram Sanghi, CEO, Sanghi Medical Centre, said, “The antibody test is different, RT-PCR  from a Covid-19 diagnostic test and helps in determining whether an individual has developed possible immunity against the disease. It will also help in learning more about the infection and recovery rate, among other things. What is more is that the test can also tell us whether a person can donate plasma or not in case they have the required antibodies. Since inception, we have been committed to ensuring that our customers get the best lab and diagnostic services, and with us they can assured of the best health outcomes.”

A RT-PCR coronavirus test looks for signs of active virus. However, it only indicates whether a person has the virus in the body at the time of testing. An antibody test, on the other hand, shows whether a person has had the virus at some point in the past – it could be gone or he/she may be still be contagious. The test will also enable in the identification of antibodies being produced to combat Covid-19.

The antibody test offered by Sanghi Medical Centre is done by the CMIA or chemiluminescence method which has a specificity & sensitivity of >99%. If the test is positive, it means the person has developed antibody and possible immunity to the disease. The lab’s accurate offering is a good way of understanding the further course of action in the fight against Covid-19 and can be done wherever the individual is: at home, in the pathlab or even in the car. Sanghi Medical ensures optimum safety, being an accredited pathlab and the results can be collected in a day’s time. The price per test is INR 1450.

Sanghi Medical Centre’s world class equipment is further augmented by the presence of some of the best doctors from diverse medical fields. They have a formidable panel of pathologists, microbiologists, radiologists, ultrasonologist, cardiologists, physicians and, highly qualified and trained laboratory technicians, radiographers and other paramedical personnel. The brand’s 200+ strong staff is relentlessly committed to the mission of delivering topnotch healthcare services to all its patients and clients. The brand’s motto is to deliver error free, on time, and every time services to all.

Hot this week

Optima Launches to Make Hedge-Fund Intelligence Personal

SEBI-registered portfolio manager introduces AI-native platform for personalized risk-aware investing

GoFloaters Introduces AI-Powered Workplace Intelligence Platform to Simplify Hybrid Workplace Management

GoFloaters’ workplace network spans 50+ cities, 360+ operators, 35,000 seats, and 4,000+ meeting rooms across India.

Bluehill.VC Announces ₹400 Crore Final Close of Maiden Frontier-Tech Fund

SIDBI, Governments of Kerala & Uttar Pradesh, family offices, founders, and UHNIs back the fund

Finvolve Backs KshatraLabs in Pre-Seed Round to Accelerate India’s Indigenous Autonomous Counter-Drone Technology

KshatraLabs aims to advance its swarm-capable interceptors to TRL-6 and progress towards defence procurement opportunities.

Topics

Optima Launches to Make Hedge-Fund Intelligence Personal

SEBI-registered portfolio manager introduces AI-native platform for personalized risk-aware investing

GoFloaters Introduces AI-Powered Workplace Intelligence Platform to Simplify Hybrid Workplace Management

GoFloaters’ workplace network spans 50+ cities, 360+ operators, 35,000 seats, and 4,000+ meeting rooms across India.

Bluehill.VC Announces ₹400 Crore Final Close of Maiden Frontier-Tech Fund

SIDBI, Governments of Kerala & Uttar Pradesh, family offices, founders, and UHNIs back the fund

Finvolve Backs KshatraLabs in Pre-Seed Round to Accelerate India’s Indigenous Autonomous Counter-Drone Technology

KshatraLabs aims to advance its swarm-capable interceptors to TRL-6 and progress towards defence procurement opportunities.

Chetan Bhambri – Leadership Strategist and Executive Coach for Founders and CXOs

The Founder Who Built a Leadership Practice Around the One Pattern Every Scaling Company Shares

Aries Agro Reports Strong Q1 FY27 Performance; Consolidated PAT Rises 49% YoY

The performance reflects resilience, operational efficiency, and continued focus on innovative plant nutrition solutions.

PayU Launches India’s First RBI-Compliant Accessible Payments Checkout for Blind and Visually Impaired Users

Ahead of Independence Day, PayU advances digital inclusion with accessibility-first checkout features for all users
spot_img

Related Articles

Popular Categories

spot_imgspot_img